<code id='36EDB69957'></code><style id='36EDB69957'></style>
    • <acronym id='36EDB69957'></acronym>
      <center id='36EDB69957'><center id='36EDB69957'><tfoot id='36EDB69957'></tfoot></center><abbr id='36EDB69957'><dir id='36EDB69957'><tfoot id='36EDB69957'></tfoot><noframes id='36EDB69957'>

    • <optgroup id='36EDB69957'><strike id='36EDB69957'><sup id='36EDB69957'></sup></strike><code id='36EDB69957'></code></optgroup>
        1. <b id='36EDB69957'><label id='36EDB69957'><select id='36EDB69957'><dt id='36EDB69957'><span id='36EDB69957'></span></dt></select></label></b><u id='36EDB69957'></u>
          <i id='36EDB69957'><strike id='36EDB69957'><tt id='36EDB69957'><pre id='36EDB69957'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:83928
          PORTRAIT of Michelle Monje smiling with trees in the background. -- health coverage from STAT.
          New research led by Stanford neuro-oncologist Michelle Monje shines light on the electrochemical signaling pathway between neurons and cancer cells. Courtesy MacArthur Foundation

          The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy brain that ordinarily lead to learning and memory formation — is gaining traction.

          First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis. Four years later, her lab revealed in a Nature paper that synapses between these neurons and gliomas spurred tumor growth, and last year, the team demonstrated how these same synapses revved up glioblastoma’s spread.

          advertisement

          There are still many questions about precisely how this process unfolds, and it’s too soon to say how solutions might be reached. But in a new paper published in Nature on Wednesday, Monje’s team solves another part of the puzzle, shining light on the electrochemical signaling pathway between neurons and cancer cells.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Amylyx ALS drug fails large clinical trial
          Amylyx ALS drug fails large clinical trial

          JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          First medicine developed to treat MASH expected to be approved soon

          MadrigalCEOBillSiboldsaysthecompanyis"interestedinthepatientswhoaremostinneed."MadrigalPharmaceutica